OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NHL.CM55

Nawaloka Hospitals PLC

Healthcare Facilities & ServicesVerified

Nawaloka Hospitals PLC has a debt-to-equity ratio of 1.58, indicating a relatively high level of leverage, and a current ratio of 0.32, suggesting limited short-term liquidity. The company's free cash flow of 541.7 million LKR supports operational flexibility, but its operating cash flow of 1.13 billion LKR is partially offset by capital expenditures of -340.7 million LKR. The company's return on equity (ROE) is 1.15%, and return on assets (ROA) is 0.28%, both of which are below the typical performance benchmarks for the healthcare sector, indicating suboptimal capital efficiency. These metrics suggest that the company is not generating strong returns relative to its equity and asset base. Nawaloka Hospitals PLC's revenue is concentrated in Sri Lanka, with no disclosed international operations. The company's business is primarily driven by domestic healthcare demand, and there is no indication of diversified geographic exposure. This concentration increases vulnerability to local economic and regulatory shifts. The company's growth trajectory is modest, with no disclosed revenue growth rates or future projections. Historical revenue of 11.01 billion LKR reflects stable operations but lacks evidence of significant expansion. The absence of clear growth drivers or strategic initiatives limits visibility into future performance. The company faces medium liquidity risk due to its current ratio of 0.32 and a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no recent or disclosed share issuance activity. However, the high debt-to-equity ratio of 1.58 suggests potential refinancing risks in the medium term. No recent events, such as filings or transcripts, have been disclosed in the available data. The company's financial and operational updates are limited to standard financial reporting, with no material developments reported in the latest available documents.

30-day price · NHL.CM+4.80 (+44.0%)
Low$10.50High$17.00Close$15.70As of15 May, 00:00 UTC
Profile
CompanyNawaloka Hospitals PLC
TickerNHL.CM
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Nawaloka Hospitals PLC operates as a provider of healthcare services in Sri Lanka, generating revenue primarily through hospital operations and outpatient services.

Classification. Nawaloka Hospitals PLC is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Nawaloka Hospitals PLC has a debt-to-equity ratio of 1.58, indicating a relatively high level of leverage, and a current ratio of 0.32, suggesting limited short-term liquidity. The company's free cash flow of 541.7 million LKR supports operational flexibility, but its operating cash flow of 1.13 billion LKR is partially offset by capital expenditures of -340.7 million LKR. The company's return on equity (ROE) is 1.15%, and return on assets (ROA) is 0.28%, both of which are below the typical performance benchmarks for the healthcare sector, indicating suboptimal capital efficiency. These metrics suggest that the company is not generating strong returns relative to its equity and asset base. Nawaloka Hospitals PLC's revenue is concentrated in Sri Lanka, with no disclosed international operations. The company's business is primarily driven by domestic healthcare demand, and there is no indication of diversified geographic exposure. This concentration increases vulnerability to local economic and regulatory shifts. The company's growth trajectory is modest, with no disclosed revenue growth rates or future projections. Historical revenue of 11.01 billion LKR reflects stable operations but lacks evidence of significant expansion. The absence of clear growth drivers or strategic initiatives limits visibility into future performance. The company faces medium liquidity risk due to its current ratio of 0.32 and a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no recent or disclosed share issuance activity. However, the high debt-to-equity ratio of 1.58 suggests potential refinancing risks in the medium term. No recent events, such as filings or transcripts, have been disclosed in the available data. The company's financial and operational updates are limited to standard financial reporting, with no material developments reported in the latest available documents.
Key takeaways
  • Nawaloka Hospitals PLC has a high debt-to-equity ratio of 1.58, indicating significant leverage.
  • The company's ROE of 1.15% and ROA of 0.28% are below typical healthcare sector benchmarks.
  • Revenue is concentrated in Sri Lanka, with no international diversification.
  • Free cash flow of 541.7 million LKR supports operations, but capital expenditures are a drag.
  • Liquidity risk is medium, and dilution risk is low based on current financials.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyLKR
Revenue$11.01B
Gross profit$5.88B
Operating income$1.01B
Net income$56.4M
R&D
SG&A
D&A
SBC
Operating cash flow$1.13B
CapEx-$340.7M
Free cash flow$541.7M
Total assets$20.02B
Total liabilities$15.11B
Total equity$4.91B
Cash & equivalents$349.8M
Long-term debt$7.78B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.91B
Net cash-$7.43B
Current ratio0.3
Debt/Equity1.6
ROA0.3%
ROE1.1%
Cash conversion20.1%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 779 companies
MetricNHL.CMActivity
Op margin9.2%7.7% medp25 -2.4% · p75 15.5%above median
Net margin0.5%5.9% medp25 -3.8% · p75 12.8%below median
Gross margin53.4%45.5% medp25 31.1% · p75 62.9%above median
R&D / revenue529.2% medp25 465.2% · p75 593.2%
CapEx / revenue-3.1%-7.0% medp25 -14.9% · p75 -3.2%top quartile
Debt / equity158.0%25.0% medp25 3.8% · p75 63.3%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 17:23 UTC#942273d8
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 18:01 UTCJob: 818dc084